Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Share-based Compensation (2017 - 2024)

Solid Biosciences (SLDB) has disclosed Share-based Compensation for 8 consecutive years, with $3.8 million as the latest value for Q4 2024.

  • Quarterly Share-based Compensation rose 97.16% to $3.8 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $10.5 million through Dec 2024, up 37.95% year-over-year, with the annual reading at $16.9 million for FY2025, 60.79% up from the prior year.
  • Share-based Compensation hit $3.8 million in Q4 2024 for Solid Biosciences, up from $3.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $3.8 million in Q4 2024 to a low of $1.5 million in Q3 2022.
  • Historically, Share-based Compensation has averaged $2.5 million across 5 years, with a median of $2.6 million in 2020.
  • Biggest five-year swings in Share-based Compensation: crashed 55.39% in 2022 and later surged 97.16% in 2024.
  • Year by year, Share-based Compensation stood at $2.5 million in 2020, then soared by 35.62% to $3.4 million in 2021, then crashed by 53.53% to $1.6 million in 2022, then grew by 22.12% to $1.9 million in 2023, then soared by 97.16% to $3.8 million in 2024.
  • Business Quant data shows Share-based Compensation for SLDB at $3.8 million in Q4 2024, $3.0 million in Q3 2024, and $2.1 million in Q2 2024.